Autolus Therapeutics plc Quarterly Operating Lease, Payments in USD from Q1 2023 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Autolus Therapeutics plc quarterly/annual Operating Lease, Payments history and growth rate from Q1 2023 to Q1 2024.
  • Autolus Therapeutics plc Operating Lease, Payments for the quarter ending March 31, 2024 was $1.73M, a 33.1% increase year-over-year.
  • Autolus Therapeutics plc annual Operating Lease, Payments for 2023 was $10.4M, a 127% increase from 2022.
  • Autolus Therapeutics plc annual Operating Lease, Payments for 2022 was $4.58M, a 0.95% decline from 2021.
  • Autolus Therapeutics plc annual Operating Lease, Payments for 2021 was $4.62M, a 5.66% decline from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.73M +$429K +33.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-17
Q1 2023 $1.3M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.